- Home
- TRT vs PYPD Comparison
TRT vs PYPD Comparison
Compare TRT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRT | PYPD |
|---|---|---|
| Founded | 1958 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.1M | 107.0M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TRT | PYPD |
|---|---|---|
| Price | $4.92 | $4.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.75 |
| AVG Volume (30 Days) | ★ 423.6K | 83.3K |
| Earning Date | 09-24-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $32,462,000.00 | N/A |
| Revenue This Year | $26.89 | N/A |
| Revenue Next Year | $25.30 | N/A |
| P/E Ratio | $365.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.63 | $3.10 |
| 52 Week High | $21.38 | $5.73 |
Technical Indicators
Market Signals| Indicator | TRT | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 22.48 | 38.28 |
| Support Level | $4.42 | $4.52 |
| Resistance Level | $6.54 | $5.07 |
| Average True Range (ATR) | 0.32 | 0.25 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 4.93 | 14.89 |
Price Performance
Historical ComparisonAbout TRT Trio-Tech International
Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.